Application of metagenomic next-generation sequencing in patients with infective endocarditis

被引:7
|
作者
Li, Shao-Lin [1 ]
Zhao, Xi [1 ]
Tao, Jun-Zhong [1 ]
Yue, Zhen-Zhen [1 ]
Zhao, Xiao-Yan [1 ]
机构
[1] Zhengzhou Univ, Cardiovasc Ctr, Dept Cardiol, Henan Key Lab Hereditary Cardiovasc Dis,Affiliated, Zhengzhou, Henan, Peoples R China
关键词
metagenomic next-generation sequencing; infective endocarditis; culture-negative; culture-positive; antibiotic regimen; CULTURE-NEGATIVE ENDOCARDITIS; CHALLENGES; DIAGNOSIS;
D O I
10.3389/fcimb.2023.1107170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesMetagenomic next-generation sequencing (mNGS) technology is helpful for the early diagnosis of infective endocarditis, especially culture-negative infective endocarditis, which may guide clinical treatment. The purpose of this study was to compare the presence of culture-negative infective endocarditis pathogens versus culture-positive ones, and whether mNGS test results could influence treatment regimens for patients with routine culture-negative infective endocarditis. MethodsThe present study enrolled patients diagnosed with infective endocarditis and tested for mNGS in the First Affiliated Hospital of Zhengzhou University from February 2019 to February 2022 continuously. According to the culture results, patients were divided into culture-negative group (Group CN, n=18) and culture-positive group (Group CP, n=32). The baseline characteristics, clinical data, pathogens, 30 day mortality and treatment regimen of 50 patients with infective endocarditis were recorded and analyzed. ResultsExcept for higher levels of PCT in the Group CN [0.33 (0.16-2.74) ng/ml vs. 0.23 (0.12-0.49) ng/ml, P=0.042], there were no significant differences in the basic clinical data and laboratory examinations between the two groups (all P>0.05). The aortic valve and mitral valve were the most involved valves in patients with infective endocarditis (aortic valve involved: Group CN 10, Group CP 16; mitral valve involved: Group CN 8, Group CP 21; P>0.05) while 9 patients had multiple valves involved (Group CN 2, Group CP 7; P>0.05). The detection rate of non-streptococci infections in the Group CN was significantly higher than that in the Group CP (9/18 vs. 3/32, P=0.004). There was no significant difference in patients with heart failure hospitalization and all-cause death at 30 days after discharge (3 in Group CN vs. 4 in Group CP, P>0.05). It is worth noting that 10 patients with culture-negative infective endocarditis had their antibiotic regimen optimized after the blood mNGS. ConclusionsCulture-negative infective endocarditis should be tested for mNGS for early diagnosis and to guide clinical antibiotic regimen.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] METAGENOMIC NEXT-GENERATION SEQUENCING DETECTS PATHOGENS IN ENDOPHTHALMITIS PATIENTS
    Zhu, Junfeng
    Xia, Honghe
    Tang, Ruqing
    Ng, Tsz Kin
    Yao, Fen
    Liao, Xulong
    Zhang, Qi
    Ke, Xixuan
    Shi, Tingkun
    Chen, Haoyu
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (05): : 992 - 1000
  • [22] Application of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in critically ill patients
    Li, Ying
    Sun, Bing
    Tang, Xiao
    Liu, Ya-lan
    He, Hang-yong
    Li, Xu-yan
    Wang, Rui
    Guo, Fei
    Tong, Zhao-hui
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (02) : 369 - 374
  • [23] Application value of blood metagenomic next-generation sequencing in patients with connective tissue diseases
    Su, Rui
    Yan, Huanhuan
    Li, Na
    Ding, Tingting
    Li, Baochen
    Xie, Yuhuan
    Gao, Chong
    Li, Xiaofeng
    Wang, Caihong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] The application of metagenomic next-generation sequencing in patients with infection or colonization caused by Lichtheimia species
    Chen, Lihua
    Peng, Weiting
    Lan, Gongbin
    Long, Guo
    Yang, Honghui
    Xu, Yajing
    Fu, Ai
    Yi, Huimin
    Wan, Qiquan
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [25] Application of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in critically ill patients
    Ying Li
    Bing Sun
    Xiao Tang
    Ya-lan Liu
    Hang-yong He
    Xu-yan Li
    Rui Wang
    Fei Guo
    Zhao-hui Tong
    European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 369 - 374
  • [26] Clinical Application of Metagenomic Next-Generation Sequencing in Sepsis Patients with Early Antibiotic Treatment
    Chen, Yongru
    Chen, Chongyue
    Chen, Wei
    Gai, Wei
    Zheng, Yafeng
    Guo, Yuxin
    Wang, Zhaoning
    Chen, Yongsong
    Cai, Zhiming
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 4695 - 4706
  • [27] Application of metagenomic next-generation sequencing (mNGS) in diagnosing pneumonia of adults
    Liu, Zhiguang
    Sun, Chuang
    Xiao, Xinru
    Zhou, Lianzheng
    Huang, Yanhua
    Shi, Yujia
    Yin, Xiaowei
    Mao, Zhengdao
    Zhang, Qian
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (11): : 1566 - 1573
  • [28] Metagenomic next-generation sequencing for the diagnosis of neurobrucellosis
    Li, Wen
    He, Ying
    Li, Yanyan
    Li, Xiaona
    Bian, Ting
    Liu, Tingting
    Liu, Xuedong
    Jiang, Wen
    FUTURE MICROBIOLOGY, 2024, 19 (06) : 509 - 518
  • [29] Metagenomic next-generation sequencing in clinical microbiology
    Jacob, Jobin John
    Veeraraghavan, Balaji
    Vasudevan, Karthick
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 37 (02) : 133 - 140
  • [30] Progress in the application of metagenomic next-generation sequencing in pediatric infectious diseases
    Li, Chi
    Wang, Yajuan
    PEDIATRICS AND NEONATOLOGY, 2022, 63 (05): : 445 - 451